+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Adult Hemoglobinopathy Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 174 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140730
The global market for Adult Hemoglobinopathy Testing is estimated at US$383.2 Million in 2023 and is projected to reach US$513.7 Million by 2030, growing at a CAGR of 4.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the adult hemoglobinopathy testing market is driven by several factors reshaping the landscape of diagnostic healthcare. Technological innovations, such as the adoption of next-generation sequencing (NGS) and advanced genetic analysis tools, are enhancing the precision and reliability of testing methods. The increasing incidence of hemoglobin disorders globally is expanding the market's addressable population, necessitating widespread and accessible diagnostic solutions. Consumer behavior trends, including heightened awareness of genetic health and proactive health management, are accelerating the demand for testing.

The integration of non-invasive and point-of-care testing methods is improving patient accessibility and convenience, further driving market adoption. Additionally, regulatory support and favorable reimbursement policies are encouraging the development and use of advanced diagnostic tools. Collaborations between diagnostic companies and healthcare providers are fostering innovation and expanding the range of available tests, ensuring comprehensive and effective disease management. These factors collectively underscore the dynamic and rapidly evolving nature of the hemoglobinopathy testing market, positioning it as a critical component in the future of personalized healthcare.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the HPLC Test segment, which is expected to reach US$314.5 Million by 2030 with a CAGR of a 4.0%. The Mass Spectrometry segment is also set to grow at 4.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $101.4 Million in 2023, and China, forecasted to grow at an impressive 6.7% CAGR to reach $110.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Adult Hemoglobinopathy Testing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Adult Hemoglobinopathy Testing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Adult Hemoglobinopathy Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as BioMedomics Inc., Bio-Rad Laboratories, Inc., Chromsystems Instruments & Chemicals GmbH, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 44 Featured):

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Adult Hemoglobinopathy Testing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advancements in Genetic Testing Propel Growth in Adult Hemoglobinopathy Testing
  • Increasing Prevalence of Hemoglobin Disorders Spurs Demand for Diagnostic Solutions
  • Expansion of Genetic Counseling Services Strengthens Business Case for Hemoglobinopathy Testing
  • Rising Awareness and Early Detection Campaigns Generate Demand for Adult Hemoglobinopathy Testing
  • Integration of Next-Generation Sequencing (NGS) in Hemoglobinopathy Testing Enhances Accuracy
  • Rising Demand for Non-Invasive Testing Methods Propels Market Growth
  • Increased Focus on Population Screening Programs Drives Adoption
  • Advances in Bioinformatics and Data Analytics Enhance Hemoglobinopathy Testing Accuracy
  • Development of Multiplexed and High-Throughput Testing Platforms Expands Market Applications
  • Increased Focus on Genetic Research and Hemoglobinopathies Propels Market Forward
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for HPLC Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Hb Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Academic & Medical Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 19: World Adult Hemoglobinopathy Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
JAPAN
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
CHINA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: China 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
EUROPE
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: France 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
GERMANY
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2024 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2024 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

Table Information